Receptor Pharmacology
Reference materials for studying the triple-receptor pharmacology that distinguishes GLP-3 from single or dual incretin agonists.
For Research Use Only
This brief describes analytical reference materials supplied by R3TA LLC for in-vitro laboratory research. It is not a protocol and contains no dosing, administration, or therapeutic guidance. Not for human or animal consumption.
GLP-3 is engineered as a balanced agonist at the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCGR) receptors.
R3TA reference materials support receptor-binding, signaling-bias, and structure-activity relationship studies in recombinant cell systems.
This framework describes analytical reference materials only and implies no fitness for any human or veterinary use.
Representative in-vitro endpoints
- —Radioligand and fluorescent-ligand competition binding across GLP-1R, GIPR, and GCGR
- —β-arrestin recruitment and G-protein signaling bias profiling
- —Receptor internalization and trafficking imaging
- —Affinity and potency determination in validated reporter cell lines
Handling & storage
- —Cold-chain shipping with temperature indicators
- —Lot-level chain-of-custody documentation
- —Retention samples held for the stated period
- —Deviation and out-of-specification handling procedure
Analytical documentation
- —Per-lot certificate of analysis
- —Method summaries available to research accounts
- —Stability program overview